GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genix Pharmaceuticals Corp (TSXV:GENX) » Definitions » Gross Margin %

Genix Pharmaceuticals (TSXV:GENX) Gross Margin % : 0.00% (As of Jan. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Genix Pharmaceuticals Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Genix Pharmaceuticals's Gross Profit for the three months ended in Jan. 2024 was C$0.00 Mil. Genix Pharmaceuticals's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Genix Pharmaceuticals's Gross Margin % for the quarter that ended in Jan. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Genix Pharmaceuticals's Gross Margin % or its related term are showing as below:

TSXV:GENX' s Gross Margin % Range Over the Past 10 Years
Min: -33.58   Med: 22.14   Max: 44.43
Current: 18.18


During the past 13 years, the highest Gross Margin % of Genix Pharmaceuticals was 44.43%. The lowest was -33.58%. And the median was 22.14%.

TSXV:GENX's Gross Margin % is ranked worse than
89.67% of 987 companies
in the Drug Manufacturers industry
Industry Median: 47 vs TSXV:GENX: 18.18

Genix Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Genix Pharmaceuticals was 0.00% per year.


Genix Pharmaceuticals Gross Margin % Historical Data

The historical data trend for Genix Pharmaceuticals's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genix Pharmaceuticals Gross Margin % Chart

Genix Pharmaceuticals Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -33.58 - - - 25.00

Genix Pharmaceuticals Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.00 - 66.67 - -

Competitive Comparison of Genix Pharmaceuticals's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Genix Pharmaceuticals's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genix Pharmaceuticals's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genix Pharmaceuticals's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Genix Pharmaceuticals's Gross Margin % falls into.



Genix Pharmaceuticals Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Genix Pharmaceuticals's Gross Margin for the fiscal year that ended in Oct. 2023 is calculated as

Gross Margin % (A: Oct. 2023 )=Gross Profit (A: Oct. 2023 ) / Revenue (A: Oct. 2023 )
=0 / 0.012
=(Revenue - Cost of Goods Sold) / Revenue
=(0.012 - 0.009) / 0.012
=25.00 %

Genix Pharmaceuticals's Gross Margin for the quarter that ended in Jan. 2024 is calculated as


Gross Margin % (Q: Jan. 2024 )=Gross Profit (Q: Jan. 2024 ) / Revenue (Q: Jan. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Genix Pharmaceuticals  (TSXV:GENX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Genix Pharmaceuticals had a gross margin of N/A% for the quarter that ended in Jan. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Genix Pharmaceuticals Gross Margin % Related Terms

Thank you for viewing the detailed overview of Genix Pharmaceuticals's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genix Pharmaceuticals (TSXV:GENX) Business Description

Traded in Other Exchanges
Address
1055 West Hastings Street, Suite 300, Vancouver, BC, CAN, V6E 1J8
Genix Pharmaceuticals Corp is a Canadian life sciences company. It operates as a formulator, manufacturer, licensor, and marketer of life sciences related products with a focus on nutraceuticals and pharmaceuticals. Some of its products are Renochlor, Sucanon, and Flu-X. The company primarily operates in Canada.
Executives
Sina Pirooz Director

Genix Pharmaceuticals (TSXV:GENX) Headlines

No Headlines